644 results on '"Real, Francisco X."'
Search Results
2. Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)
3. In Vitro Bladder Cancer Models
4. The urothelial gene regulatory network: understanding biology to improve bladder cancer management
5. Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids
6. List of contributors
7. GATA6 identifies an immune-enriched phenotype linked to favorable outcomes in patients with pancreatic cancer undergoing upfront surgery
8. NFIC regulates ribosomal biology and ER stress in pancreatic acinar cells and restrains PDAC initiation
9. Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities
10. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights
11. Deciphering the roadmap of in vivo reprogramming toward pluripotency
12. Comparison of spatial transcriptomics technologies across six cancer types
13. A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer
14. Essential Roles of Cohesin STAG2 in Mouse Embryonic Development and Adult Tissue Homeostasis
15. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
16. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns
17. GATA6 identifies an immune-enriched phenotype linked to favorable outcomes in patients with pancreatic cancer undergoing upfront surgery
18. The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver
19. Bptf determines oncogenic addiction in aggressive B-cell lymphomas
20. Publisher Correction: Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
21. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
22. Mouse Models Shed Light on the SLIT/ROBO Pathway in Pancreatic Development and Cancer
23. What is a Bladder Cancer Molecular Subtype? – Counterpoint
24. The urothelial gene regulatory network: understanding biology to improve bladder cancer management
25. HNF1A plays a context-dependent role in pancreatic cancer initiation and progression
26. The protective effect of atopic diseases against pancreatic cancer is not driven by Th2-biomarkers
27. Integration of metabolome and microbiome omics layers toward pancreatic cancer risk prediction
28. Complement system genetic variability shapes pancreatic cancer risk
29. Animal Modeling of Pancreatitis-to-Cancer Progression
30. Mutant Kras Dosage and Chromothripsis: The Right Ingredients for a Pancreatic Cancer Catastrophe
31. PDAC heterogeneity resolved spatially at the single‐cell level: new biological answers, new questions on optimal translation†.
32. Table S1 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
33. Data from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
34. Figure S1 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
35. Supplementary Figure S2 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
36. Supplementary Table S6 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
37. Data from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
38. Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological features
39. Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study
40. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset
41. FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study
42. Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy
43. Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
44. HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer
45. Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
46. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
47. Data from Tumor and Stromal Cell Targeting with Nintedanib and Alpelisib Overcomes Intrinsic Bladder Cancer Resistance
48. Supplementary Data from Tumor and Stromal Cell Targeting with Nintedanib and Alpelisib Overcomes Intrinsic Bladder Cancer Resistance
49. The N-Terminal Phosphorylation of RB by p38 Bypasses Its Inactivation by CDKs and Prevents Proliferation in Cancer Cells
50. Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.